Consumers Could Get Up to $50 or More From The Settlement
New Orleans, LA, September 9, 2013 -- The following is being released by the law firms of Herman, Herman & Katz, LLC and Leiff Cabraser Heimann & Bernstein.
Merck Sharp & Dohme Corp. (“Merck”) has agreed to pay up to $23 million to settle a class action lawsuit involving the prescription anti-inflammatory drug Vioxx. The lawsuit claims Merck falsely advertised Vioxx as having greater benefits than less expensive medicines contradicting FDA approved labeling. Merck denies these claims but has agreed to a settlement.
Consumers who paid for all or part of the cost of Vioxx before October 1, 2004 are included in the settlement.